Training Courses, Membership, Publications | Research Quality Association

Explore key phases of process and system auditing

Practical Approach to Auditing Systems and Processes, 21st-22nd May 2019
More Information
Spring Sale 2019

15% courses, eLearning and webcasts until 3rd May 2019.
View Code
Quasar 147 Now Available Online

This edition has the theme Impact.
View Now

Featured Pages

Key facts

The number of new RQA members who join the Association each year. We currently have just over 2200 members.

The number of Committee Members in 2018, these volunteers help with everything from new booklets to conference organisation.

The Association is forty years old.

Who are RQA

The Research Quality Association (RQA) is a professional membership body dedicated to informing and advancing its members. We provide status and visibility for individuals engaged in the quality of research concerning pharmaceuticals, agrochemicals, chemicals and medical devices. Since our inception in 1977, the Association has increased and evolved to reflect regulatory changes, the growing impact of regulatory inspection and the ever-changing structure and needs of industry. RQA's purpose is to drive quality and integrity in scientific research.

Read more+

Our Mission

1. To develop and promote quality standards in scientific research.

2. To facilitate knowledge sharing and transfer through:

Discussion
Training
Seminars
Forums
Conferences
Publications
Podcasts
Partnership and co-operation

3. To liaise with regulatory agencies in the development and interpretation of regulations and guidance.

Latest News

View all news

Brexit: EU supports pharmaceutical Companies

Medicinal products imported into the EU must undergo batch testing within the EU and the European Economic Area (EEA)*. Once the United Kingdom (UK) leaves the EU (Brexit), pharmaceutical manufacturers who have previously carried out batch testing in the UK must relocate their batch testing operations to the EU/EEA in order to import their products.

Read more+

Brexit: Handling PV Data from the UK

The European Medicines Agency (EMA) has updated the agency's Brexit-related guidance documents. This guidance is supporting pharmaceutical companies to prepare for the United Kingdom's (UK) withdrawal from the European Union (EU). Now the 'Questions and Answers' document has been updated (Rev 04, published on 1st February 2019). The new Q&As address the situation when the United Kingdom becomes a third country on 30th March 2019 without a withdrawal agreement (and hence without a transition period).

Read more+

Brexit-related guidance for companies

The European Medicines Agency (EMA) and the European Commission are providing guidance to help pharmaceutical companies responsible for both human and veterinary medicines prepare for the United Kingdom's (UK) withdrawal from the European Union (EU), a process known as 'Brexit'.

Read more+